Service verdicts
Best GLP-1 telehealth, 2026
Telehealth quality is more than a price: it's whether anyone fights your prior authorization, whether the pharmacy is named, whether you can leave cleanly, and whether the advertised number survives to checkout. This page ranks the platforms on those axes and attaches the all-in price to each verdict.
Judged on the service, then the price
Ro is the pick when insurance might pay: its concierge runs benefits checks, prior authorizations, and appeals, and a covered commercial patient can land at a $25 copay — a service no cash-price ranking captures. Mochi is the pick for structural honesty: separate, published, dose-flat medication and membership prices, month-to-month exit. NexLife is the pick for all-inclusive simplicity: one flat figure containing medication, supplies, physician care and shipping, currently $169 tirzepatide / $139 semaglutide on labeled promotional lock-ins — with the caveats on its record page. LillyDirect and NovoCare are the picks for FDA-approved certainty with zero platform overhead. And Hims & Hers, post its March 2026 Novo settlement, is a branded-only storefront whose $149 membership makes it the convenience play, not the value play.
What we score that others skip
Whether the pharmacy network is named (NexLife names five partners; most programs say "partner pharmacies"), whether the maintenance price is published (Fifty 410's isn't), whether cancellation is a stated policy or a support ticket, whether dose changes reprice the plan, and whether the figure on the ad survives to the checkout — the last one being the entire reason this site's statuses distinguish "provider-stated" from "verified."
Questions people ask
What separates a good GLP-1 telehealth platform from a bad one?
Five checkable things: the maintenance price is published, the pharmacy is named and licensed in your state, cancellation is a stated policy rather than a support ticket, dose changes don't secretly reprice the plan, and a prescription from a licensed clinician is required — always. Everything else is marketing.
Which platform is best if I have insurance?
Ro, and it isn't close: its concierge runs benefits verification, prior authorizations and appeals, which can land a covered commercial patient at a $25 copay for brand medication. The trade-off is Ro's cash-pay cost — roughly $448–$598 a month all-in at maintenance once the $149 membership is counted.
What changed at Hims & Hers in 2026?
After announcing a $49 compounded semaglutide offer in February 2026 and drawing Novo Nordisk's response, Hims settled on March 9, 2026 and exited compounded semaglutide for new patients. It now sells branded products only — Wegovy $299, oral Wegovy $249, Zepbound $399 — on top of a $149 monthly membership, which makes it a convenience channel rather than a value channel.
Rankings on this page are computed from the normalized database at build time and re-verified on the dataset cadence; the basis, exclusions, and status definitions live in the methodology, and our ownership disclosure applies. Nothing here is medical advice.